Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Effects of albendazole combined with TSII-A (a Chinese herb compound) on optic neuritis caused by Angiostrongylus cantonensis in BALB/c mice.
Does long term treatment with azathioprine predispose to malignancy and death in patients with systemic lupus erythematosus?
Autoimmune disorders after immunisation with Influenza A/H1N1 vaccines with and without adjuvant: EudraVigilance data and literature review.
Long-term outcome of paediatric-onset multiple sclerosis: a population-based study.
Evaluating risks, costs, and benefits of new and emerging therapies to optimize outcomes in multiple sclerosis.
Imaging and diagnostic criteria for Multiple Sclerosis: Are we there yet?
What went wrong? The flawed concept of cerebrospinal venous insufficiency.
Regulated Extracellular Choline Acetyltransferase Activity- The Plausible Missing Link of the Distant Action of Acetylcholine in the Cholinergic Anti-Inflammatory Pathway.
A Case Report of Obsessive-Compulsive Disorder Following Acute Disseminated Encephalomyelitis.
Connexin 43 astrocytopathy linked to rapidly progressive multiple sclerosis and neuromyelitis optica.
Accurate white matter lesion segmentation by k nearest neighbor classification with tissue type priors (kNN-TTPs).
Quality of life and employment in persons with multiple sclerosis.
Fingolimod-associated macular edema: resolution by sub-tenon injection of triamcinolone with continued fingolimod use.
Season of infectious mononucleosis and risk of multiple sclerosis at different latitudes; the EnvIMS Study.
Tolerogenic dendritic cells produced by Lentiviral-mediated CD40- and IL-23p19-specific shRNA can ameliorate experimental autoimmune encephalomyelitis by suppressing Th17 cells.
Multiple sclerosis: Insights into pathophysiology and novel therapeutic avenues.
Falls in people with MS-an individual data meta-analysis from studies from Australia, Sweden, United Kingdom and the United States.
Signaling networks in MS: A systems-based approach to developing new pharmacological therapies.
Alemtuzumab Induced Thyroid Disease in Multiple Sclerosis: A Review and Approach to Management.
A Sphingosine-1-Phosphate Receptor 1-Directed Agonist Reduces Central Nervous System Inflammation in a Plasmacytoid Dendritic Cell-Dependent Manner.
The Use of Fourth-generation Optical Coherence Tomography in Multiple Sclerosis: A Review.
The role of kinin B1 and B2 receptors in the persistent pain induced by experimental autoimmune encephalomyelitis (EAE) in mice: Evidence for the involvement of astrocytes.
Sustained TNF production by central nervous system infiltrating macrophages promotes progressive autoimmune encephalomyelitis.
Will Biomarkers Determine What Is Next in Multiple Sclerosis?: Biomarkers in Multiple Sclerosis.
Acute retinal necrosis in multiple sclerosis: A neuroimmunologic challenge!

Pages